Suven Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of March 2025: 6.76%

Suven Pharmaceuticals Limited (SUVENPHAR) has an Asset Resilience Ratio of 6.76% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs2.05 Billion

≈ $22.17 Million USD Cash + Short-term Investments

Total Assets

Rs30.32 Billion

≈ $327.87 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Suven Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Check Suven Pharmaceuticals Limited strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Suven Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Suven Pharmaceuticals Limited worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.05 Billion	6.76%
Total Liquid Assets	Rs2.05 Billion	6.76%

Asset Resilience Insights

Limited Liquidity: Suven Pharmaceuticals Limited maintains only 6.76% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Suven Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Suven Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Suven Pharmaceuticals Limited (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Suven Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	6.76%	Rs2.05 Billion ≈ $22.17 Million	Rs30.32 Billion ≈ $327.87 Million	-27.57pp
2024-03-31	34.33%	Rs7.74 Billion ≈ $83.69 Million	Rs22.54 Billion ≈ $243.77 Million	+12.84pp
2023-03-31	21.49%	Rs4.22 Billion ≈ $45.68 Million	Rs19.66 Billion ≈ $212.59 Million	-4.81pp
2022-03-31	26.30%	Rs4.81 Billion ≈ $52.04 Million	Rs18.30 Billion ≈ $197.86 Million	+14.05pp
2021-03-31	12.25%	Rs1.81 Billion ≈ $19.53 Million	Rs14.74 Billion ≈ $159.46 Million	+9.63pp
2020-03-31	2.62%	Rs306.76 Million ≈ $3.32 Million	Rs11.73 Billion ≈ $126.84 Million	+1.71pp
2019-03-31	0.90%	Rs70.64 Million ≈ $763.92K	Rs7.83 Billion ≈ $84.68 Million	--

pp = percentage points

About Suven Pharmaceuticals Limited

NSE:SUVENPHAR India Drug Manufacturers - Specialty & Generic

Market Cap

$4.40 Billion

Rs406.97 Billion INR

Market Cap Rank

#3849 Global

#173 in India

Share Price

Rs1063.80

Change (1 day)

+0.00%

52-Week Range

Rs1063.80 - Rs1063.80

All Time High

Rs1334.20